These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 17227289)

  • 21. Effect of doxapram on episodes of apnoea, bradycardia and hypoxaemia in preterm infants.
    Poets CF; Darraj S; Bohnhorst B
    Biol Neonate; 1999 Oct; 76(4):207-13. PubMed ID: 10473894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TASK-1 (KCNK3) and TASK-3 (KCNK9) tandem pore potassium channel antagonists stimulate breathing in isoflurane-anesthetized rats.
    Cotten JF
    Anesth Analg; 2013 Apr; 116(4):810-6. PubMed ID: 23460565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of doxapram, prethcamide and lobeline on spirometric, blood gas and acid-base variables in healthy new-born calves.
    Bleul U; Bylang T
    Vet J; 2012 Nov; 194(2):240-6. PubMed ID: 22609153
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the recovery and respiratory effects of aminophylline and doxapram following total intravenous anesthesia with propofol and remifentanil.
    Kim DW; Joo JD; In JH; Jeon YS; Jung HS; Jeon KB; Park JS; Choi JW
    J Clin Anesth; 2013 May; 25(3):173-6. PubMed ID: 23583458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The ventilatory stimulant doxapram inhibits TASK tandem pore (K2P) potassium channel function but does not affect minimum alveolar anesthetic concentration.
    Cotten JF; Keshavaprasad B; Laster MJ; Eger EI; Yost CS
    Anesth Analg; 2006 Mar; 102(3):779-85. PubMed ID: 16492828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A pharmacologic respiratory stimulant, doxapram, used in acute deterioration in patients with chronic respiratory failure].
    Andersen JB; Jensen NH; Klausen NO
    Ugeskr Laeger; 1989 Jul; 151(28):1820-2. PubMed ID: 2672485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of alfentanil pre-treatment on ventilatory effects of doxapram following induction of anaesthesia with propofol.
    O'Connor B; Levy DM; Peacock JE
    Acta Anaesthesiol Scand; 1996 Feb; 40(2):156-9. PubMed ID: 8848912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low cost of pulmonary ventilation in American alligators (Alligator mississippiensis) stimulated with doxapram.
    Skovgaard N; Crossley DA; Wang T
    J Exp Biol; 2016 Apr; 219(Pt 7):933-6. PubMed ID: 26896538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective study shows that doxapram therapy avoided the need for endotracheal intubation in most premature neonates.
    Flint R; Halbmeijer N; Meesters N; van Rosmalen J; Reiss I; van Dijk M; Simons S
    Acta Paediatr; 2017 May; 106(5):733-739. PubMed ID: 28130789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of doxapram on the respiratory rhythmical discharge activity in the brainstem slice of neonatal rats].
    Li GC; Jiao YG; Wu ZH; Fang F; Cheng J
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Feb; 30(2):245-8. PubMed ID: 20159691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doxapram revisited in patients with cancer.
    Li E; Sritharan G; Mogos M; Roffey P; Thangathurai D
    J Palliat Med; 2009 Aug; 12(8):673. PubMed ID: 19663568
    [No Abstract]   [Full Text] [Related]  

  • 32. Towards evidence based emergency medicine:PRIVATE best BETs from the Manchester Royal Infirmary. Bet 2: doxapram resurrected? Weak evidence of efficacy suggests a potential use in patients ineligible for non-invasive ventilation.
    Emerg Med J; 2012 Jan; 29(1):78-80. PubMed ID: 22186269
    [No Abstract]   [Full Text] [Related]  

  • 33. Ventilatory and pulmonary hemodynamic response to the respiratory stimulant doxapram in chronic bronchitis.
    Conti F; Bertoli L; Bertoli M; Mantero O
    Pharmacol Res Commun; 1976 Jun; 8(3):243-51. PubMed ID: 800260
    [No Abstract]   [Full Text] [Related]  

  • 34. The effects of doxapram hydrochloride (dopram-V) on laryngeal function in healthy dogs.
    Miller CJ; McKiernan BC; Pace J; Fettman MJ
    J Vet Intern Med; 2002; 16(5):524-8. PubMed ID: 12322700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Respiratory stimulant drugs in the post-operative setting.
    Golder FJ; Hewitt MM; McLeod JF
    Respir Physiol Neurobiol; 2013 Nov; 189(2):395-402. PubMed ID: 23791825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of doxapram on obstructive sleep apnea.
    Suratt PM; Wilhoit SC; Brown ED; Findley LJ
    Bull Eur Physiopathol Respir; 1986; 22(2):127-31. PubMed ID: 3708186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of the ventilatory stimulant, doxapram on human TASK-3 (KCNK9, K2P9.1) channels and TASK-1 (KCNK3, K2P3.1) channels.
    Cunningham KP; MacIntyre DE; Mathie A; Veale EL
    Acta Physiol (Oxf); 2020 Feb; 228(2):e13361. PubMed ID: 31423744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of the respiratory stimulant doxapram in southern elephant seals (Mirounga leonina).
    Woods R; McLean S; Nicol S; Slip DJ; Burton HR
    Vet Rec; 1996 May; 138(21):514-7. PubMed ID: 8761974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiologic effects of doxapram in idiopathic apnea of prematurity.
    Barrington KJ; Finer NN; Peters KL; Barton J
    J Pediatr; 1986 Jan; 108(1):124-9. PubMed ID: 3080569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolated mental developmental delay in very low birth weight infants: association with prolonged doxapram therapy for apnea.
    Sreenan C; Etches PC; Demianczuk N; Robertson CM
    J Pediatr; 2001 Dec; 139(6):832-7. PubMed ID: 11743509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.